SymbolTECH
NameBIO-TECHNE CORP
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Address614 MCKINLEY PLACE N.E., MINNEAPOLIS, Minnesota, 55413, United States
Telephone+1 612 379-8854
Fax
Email
Websitehttps://www.bio-techne.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0000842023
Description

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Additional info from NASDAQ:
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

2026-08-13 10:30

Bio-Techne Corrects Dividend Announcement

Read more
2026-08-13 10:30

Bio-Techne Corrects Dividend Announcement

Read more
2026-08-12 10:30

(30% Negative) BIO-TECHNE CORP (TECH) Reports Q3 2026 Financial Results

Read more
2026-08-12 10:30

Bio-Techne Declares Dividend

Read more
2026-08-12 10:30

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

Read more
2026-08-12 10:30

Bio-Techne Declares Dividend

Read more
2026-08-12 10:30

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

Read more
2026-08-10 17:35

New Form PREM14A - BIO-TECHNE Corp <b>Filed:</b> 2026-08-10 <b>AccNo:</b> 0001140361-26-032037 <b>Size:</b> 4 MB

Read more
2026-07-31 21:18

Hippel James 🟡 adjusted position in 566.5K shares (14 derivative) of BIO-TECHNE Corp (TECH) at $120.46 ($41.4M) Transaction Date: Jul 29, 2026 | Filing ID: 000108

Read more
2026-07-30 20:11

Director Kelderman Kim 🟡 adjusted position in 720.9K shares (17 derivative) of BIO-TECHNE Corp (TECH) at $120.46 ($40.9M) Transaction Date: Jul 28, 2026 | Filing ID: 000106

Read more